CTRI/2017/01/007711尚未招募未知
Open, multicenter, randomized, comparative study of efficacy and safety ofpharmaceutical products Formair metered-dose inhaler, 12 μgand Atimos, aerosol in the metered-dose inhaler, 12 μg in patients with partlycontrolled bronchial asthma. - FormoterolMDI
Rus Biopharm0 个研究点目标入组 150 人开始时间: 待定最近更新:
相关药物
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The diagnosis of persistent bronchial asthma (BA) is determined according to the Guidelines GINA (2015) not less than 6 months before the screening visit
- •The need for combined broncholytic therapy with long-acting β-agonist (LABA) together with inhaled glucocorticosteroids (IGCS)
- •The results of the questionnaire ACQ-5 >= 0.75 and <1.5 points
排除标准
- •Patients in need of the selected starting supporting therapy of asthma.
- •Contraindications to IGCS therapy, hypersensitivity to Formoterol, Salbutamol, or any component of the study drug, reference drug and Salbutamol.
- •Body mass index (BMI) > 35 kg/m 2.
- •Chronic obstructive pulmonary disease (COPD), according to the version of the GOLD Guidelines (2015) has been diagnosed.
研究者
相似试验
进行中（未招募）
不适用
Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of Concomitant versus Separate administration of a combined measles, mumps, rubella and varicella live vaccine ProQuad and a Booster dose of Infanrix hexa in Healthy Children 12 to 23 months of age - X06-MMRV-302EUCTR2006-004129-27-ITCASA MADRE960
进行中（未招募）
1 期
ANTICIPUSC: Preoperative anticipation of respiratory risk according to ARISCAT scoring system and prophylactic post-operative non-invasive ventilation, comparing to standard post-operative care in patients at high-risk of respiratory complicationsEUCTR2017-001011-36-FRINSTITUT DE CANCEROLOGIE DE L'OUEST266
进行中（未招募）
1 期
An open, randomised, multicentre study to compare buprenorphine transdermal delivery system (BTDS) with standard treatment in elderly subjects with OA of the hip and/or knee.Severe osteoarthritic pain of the hip(s) and/or knee(s)MedDRA version: 8.0 Level: PT Classification code 10003239EUCTR2005-004279-39-GBapp Pharmaceuticals Limited
进行中（未招募）
不适用
An open, randomised, comparative, multicentre study of the immunogenicity and safety of concomitant versus separate administration of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) and a booster dose of Infanrix® hexa in healthy children 12 to 23 months of age.EUCTR2006-004129-27-DESanofi Pasteur MSD960
进行中（未招募）
不适用
An open, randomised, comparative, multicentre study of the immunogenicity and safety of M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® when administered concomitantly by intramuscular (IM) route or subcutaneous (SC) route at two separate injection sites in healthy subjects 12 to 18 months of age - MMR rHA + VARIVAX IM or SC in 12-18 month-old healthy subjectsot applicable - Healthy subjectsEUCTR2004-002586-21-DEAventis Pasteur MSD SNC700